ASPB Signs Letter to Eliminate Barriers to FDA’s Draft Guidance on Gene Editing
On April 19, 2022, the Ag Biotech Alliance, of which ASPB is a member, sent a letter to key members of Congress to include in the Fiscal Year 2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Agriculture) Appropriations bill to provide the U.S. Food and Drug Administration (FDA) the necessary resources to … Read more